Viagra-like drug approved in US to help women with libido

REGULATORS in the US have approved a drug that some describe as the first female Viagra.

The drug, flibanserin, to be sold under the name Addyi, has received the go-ahead from the Food and Drug Administration after being knocked back in 2010 and 2013.

It works on neurotransmitters in the brain to boost the libido of women who have lost interest in sex. It is intended to treat women who have not yet entered menopause and who have hypoactive sexual desire disorder (HSDD).

The director of the FDA's Centre for Drug Evaluation and Research, Janet Woodcock, told AFP: "Today's approval provides women distressed by their low sexual desire with an approved treatment option."

The FDA warns, however, the drug can have side-effects - including nausea, dizziness, sleepiness and low blood pressure - and must not be taken with alcohol.

"Patients and prescribers should fully understand the risks associated with the use of Addyi before considering treatment," Ms Woodcock said.

The disorder can reportedly develop in women who previously have been sexually active.



Coffs MKR sisters draw in more than a million viewers

Coffs MKR sisters draw in more than a million viewers

Coffs sisters push up MKR rating with leader board topping dishes

Coffs business fined more than $20,000 for false claims

Coffs business fined more than $20,000 for false claims

Credit repair business penalised for false claims

From market garden to market leader

From market garden to market leader

New property development comes with a dose of history

Local Partners